NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.6228
+0.0076 (1.24%)
At close: May 12, 2025, 4:00 PM
0.6317
+0.0089 (1.43%)
After-hours: May 12, 2025, 6:08 PM EDT
NMTC Revenue
NeuroOne Medical Technologies had revenue of $3.27M in the quarter ending December 31, 2024, with 234.90% growth. This brings the company's revenue in the last twelve months to $5.75M, up 104.21% year-over-year. In the fiscal year ending September 30, 2024, NeuroOne Medical Technologies had annual revenue of $3.45M with 1.33% growth.
Revenue (ttm)
$5.75M
Revenue Growth
+104.21%
P/S Ratio
3.05
Revenue / Employee
$338,207
Employees
17
Market Cap
29.51M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
Sep 30, 2020 | 1.93M | - | - |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
NMTC News
- 11 hours ago - NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor - GlobeNewsWire
- 7 days ago - NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference - Newsfile Corp
- 11 days ago - NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time - GlobeNewsWire
- 19 days ago - NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain - GlobeNewsWire
- 26 days ago - NeuroOne® Issues Letter to Shareholders - GlobeNewsWire
- 4 weeks ago - NeuroOne® OneRF® Technology Success Story Featured on Fox News - GlobeNewsWire
- 5 weeks ago - Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet - Benzinga
- 5 weeks ago - NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock - GlobeNewsWire